Should You Buy, Sell or Hold CrowdStrike Stock Before Q3 Earnings?

CrowdStrike guided fiscal Q3 revenues of $1.208B–$1.218B and non-GAAP EPS of $0.93–$0.95 versus Zacks consensus revenue of $1.21B (implying +20.2% YoY) and EPS consensus of $0.94 (+1.1% YoY). The business shows strong ARR momentum — total ARR $4.66B (+20% YoY), SIEM ARR >$430M (+95% YoY) — driven by Falcon Flex adoption (1,000+ customers, 100+ re-Flex renewals) and AI features like Charlotte AI, but valuation is stretched (forward 12‑month P/S 22.41 vs industry 12) and elevated R&D/S&M spending (R&D up ~12x, S&M up ~9x to $1.52B in fiscal 2025), leading Zacks to a cautious/hold stance. Investors should weigh robust top-line and product momentum against shrinking near-term margins and premium multiples.

Analysis

Market structure: CrowdStrike (CRWD) is the near-term beneficiary of secular demand for cloud-native security — Falcon Flex and Next‑Gen SIEM (SIEM ARR +95% YoY to ~$430m) position CRWD to win replacement deals from legacy vendors (Checkpoint, legacy SIEM vendors, SentinelOne). That increases pricing power on ingestion-based SIEM economics but also concentrates upside in a handful of large re‑Flex deals (>100 re‑Flex customers driving ~+50% ARR uplift in examples), leaving valuation stretched (forward P/S 22.4 vs industry 12) and sensitive to execution noise.

Risk assessment: Near-term tail risks include a material guidance miss on Dec 2 (revenues guided ~$1.208–1.218bn; EPS $0.93–0.95) that could trigger a >15% share re‑price; medium-term risks are margin degradation from sustained high S&M/R&D spend (S&M grew ~9x since FY2019 to $1.52bn) and regulatory/AI controls that raise go‑to‑market friction. Immediate window: earnings volatility days; short term (1–6 months): re‑Flex conversion cadence and SIEM net retention; long term (1–3 years): sustained ARR expansion and gross margin leverage.

Trade implications: Tactical size is key — establish small, hedged exposure ahead of Dec 2 (2–3% portfolio weight) and look to add on disciplined triggers: ARR growth >=20% YoY or SIEM ARR growth >60% sequentially. Pair trade: long CRWD vs short S (SentinelOne) 1:1 to express better execution and ARR durability; options: use a 1‑month collar around earnings (buy 10% OTM put, sell 15% OTM call) or buy a 3‑6 month call spread if post‑earnings guidance is constructive.

Contrarian angles: The market may underprice embedded expansion from Charlotte AI and re‑Flex stickiness — if Charlotte adoption doubles sequentially (usage was +85% q/q), upside to ARR and retention is non‑linear. Conversely, the premium multiple (P/S >22) makes CRWD more vulnerable to modest misses; historical parallel: Splunk’s cloud transition shows early margin pain but durable ARR upside — trade sizing should assume 20–30% downside on a guide miss and 20–30% upside on sustained ARR acceleration.

Key Decisions for Investors

• Establish a 2–3% long position in CRWD ahead of the Dec 2 earnings report, hedged with a 1‑month 10% OTM put and financed by selling a 15% OTM call (collar) to limit downside while keeping upside participation.
• If CRWD reports ARR growth <15% YoY or SIEM ARR sequential growth <50% on Dec 2, reduce CRWD exposure by 50% within 2 trading days; if ARR >=20% and management cites >100 new Falcon Flex customers converting, add up to an incremental 2% position within 5 trading days.
• Implement a pair trade: long CRWD (1%) versus short S (SentinelOne) (1%) to express share‑gain and execution divergence — rebalance after 3 months or if relative performance exceeds ±15%.
• Post‑earnings (within 1–4 weeks), consider buying a 3–6 month call spread on CRWD if forward 12‑month P/S compresses to <=18 or the stock drops >=10% on non‑structural news; avoid unhedged long positions while P/S >20.